Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer
Recruiting · NCT03026140 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colon carcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Recruiting | Phase 2 | 2026-09-30 | NCT03026140 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| The Netherlands Cancer Institute | 113 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Catharina Ziekenhuis | Eindhoven | Netherlands | 43 |
| Haga Ziekenhuis | The Hague | Netherlands | 10 |
| Marieke van de Belt | Amsterdam | Netherlands | 2 |
| OLVG | Amsterdam | Netherlands | 21 |
| Spaarne Ziekenhuis | Haarlem | Netherlands | 1 |
| Tergooi | Hilversum | Netherlands | 4 |